Future studies should further explore the expression differences of β-Klotho in different populations, ages, obesity degrees and metabolic states, and clarify the value of combined detection of β-Klotho, α-Klotho, FGF23 and other molecules in the risk prediction of diabetes and metabolic syndrome. This evidence concerns the gene KLB and Obesity.